Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High rates of durable response are achieved with imatinib after treatment with interferon alpha plus cytarabine: results from the International Randomized Study of Interferon and STI571 (IRIS) trial.
Guilhot F, Druker B, Larson RA, Gathmann I, So C, Waltzman R, O'Brien SG. Guilhot F, et al. Among authors: waltzman r. Haematologica. 2009 Dec;94(12):1669-75. doi: 10.3324/haematol.2009.010629. Epub 2009 Jul 31. Haematologica. 2009. PMID: 19648168 Free PMC article. Clinical Trial.
Sustained durability of responses and improved progression-free and overall survival with imatinib treatment for accelerated phase and blast crisis chronic myeloid leukemia: long-term follow-up of the STI571 0102 and 0109 trials.
Silver RT, Cortes J, Waltzman R, Mone M, Kantarjian H. Silver RT, et al. Among authors: waltzman r. Haematologica. 2009 May;94(5):743-4. doi: 10.3324/haematol.2009.006999. Haematologica. 2009. PMID: 19407320 Free PMC article. No abstract available.
Phase II study of "dose-dense" high-dose chemotherapy treatment with peripheral-blood progenitor-cell support as primary treatment for patients with advanced ovarian cancer.
Aghajanian C, Fennelly D, Shapiro F, Waltzman R, Almadrones L, O'Flaherty C, O'Conner K, Venkatraman E, Barakat R, Curtin J, Brown C, Reich L, Wuest D, Norton L, Hoskins W, Spriggs DR. Aghajanian C, et al. Among authors: waltzman r. J Clin Oncol. 1998 May;16(5):1852-60. doi: 10.1200/JCO.1998.16.5.1852. J Clin Oncol. 1998. PMID: 9586901 Clinical Trial.
Phase II trial of paclitaxel in patients with soft-tissue sarcoma.
Casper ES, Waltzman RJ, Schwartz GK, Sugarman A, Pfister D, Ilson D, Woodruff J, Leung D, Bertino JR. Casper ES, et al. Among authors: waltzman rj. Cancer Invest. 1998;16(7):442-6. doi: 10.3109/07357909809011697. Cancer Invest. 1998. PMID: 9774950 Clinical Trial.
18 results